+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pharmacokinetic, bacteriological and clinical studies on sulbactam/ampicillin in pediatric field



Pharmacokinetic, bacteriological and clinical studies on sulbactam/ampicillin in pediatric field



Japanese Journal of Antibiotics 42(3): 639-650



Clinical trials were carried out on the use of sulbactam/ampicillin (SBT/ABPC) (combination rate of 1:2) in pediatric infections. Results were as follows: 1. The mean half-lives of SBT and ABPC in the serum following intravenous injection of SBT/ABPC were about 1.05 and 0.90 hours, respectively. 2. The mean urinary excretions of SBT and ABPC in 6 hours after intravenous injection of SBT/ABPC were 71.2% and 62.2%, respectively. 3. SBT/ABPC was administered to 23 pediatric patients with various infections: 17 patients with pneumonia, 3 with tonsillitis, 2 with urinary tract infection and 1 with cervical lymphadenitis. The overall efficacy rate was 95.7%. In particular, 2 urinary tract infections caused by highly beta-lactamase producing Escherichia coli were improved by the treatment with SBT/ABPC. 4. No adverse reactions were observed except 2 cases of mild diarrhea. Abnormal laboratory test values included thrombocytosis in 4 and slight elevation of GOT and GPT in 1, but they were transient.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040956795

Download citation: RISBibTeXText

PMID: 2746847


Related references

Bacteriological, pharmacokinetic and clinical studies of sulbactam/ampicillin in the pediatric field. Japanese Journal of Antibiotics 42(3): 719-724, 1989

Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients. Japanese Journal of Antibiotics 42(3): 773-790, 1989

Pharmacokinetic and clinical studies on sulbactam/ampicillin in the pediatric field. Japanese Journal of Antibiotics 42(3): 651-661, 1989

Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field. Japanese Journal of Antibiotics 37(12): 2427-2456, 1984

Pharmacokinetic and bacteriological studies on sulbactam/ampicillin in the field of pediatrics. Japanese Journal of Antibiotics 42(3): 579-593, 1989

Pharmacokinetic, bacteriological and clinical evaluation of sulbactam/ampicillin in pediatrics. Japanese Journal of Antibiotics 42(3): 743-753, 1989

Laboratory and clinical studies of sulbactam/ampicillin in pediatric field. Japanese Journal of Antibiotics 42(3): 687-700, 1989

Pharmacokinetic and clinical studies on sulbactam/ampicillin in children. Japanese Journal of Antibiotics 42(3): 701-717, 1989

Clinical study on sulbactam/ampicillin in the pediatric field. Japanese Journal of Antibiotics 42(3): 725-731, 1989

Clinical experience with sulbactam/ampicillin in the pediatric field. Japanese Journal of Antibiotics 42(3): 733-742, 1989

Bacteriological, pharmacokinetic and clinical studies on biapenem (L-627) in the pediatric field. Japanese Journal of Antibiotics 47(12): 1728-1752, 1994

Pharmacokinetic, bacteriological and clinical studies on cefozopran in the pediatric field. Japanese Journal of Antibiotics 47(11): 1589-1611, 1994

Pharmacokinetic, bacteriological and clinical studies in the pediatric field on norfloxacin. Japanese Journal of Antibiotics 43(5): 799-807, 1990

Pharmacokinetic, bacteriological and clinical studies of SY5555 in the pediatric field. Japanese Journal of Antibiotics 48(2): 238-260, 1995

Bacteriological pharmacokinetic and clinical studies on aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3195-3216, 1985